The next year, after several scientific articles were published suggesting a link between sucrose and coronary heart disease, the SRF approved the literature-review project. It wound up paying ...

A startling new report published today in JAMA Internal Medicine found that more than 50 years ago ... the Sugar Research Foundation (SRF), now known as the Sugar Association, did not reveal ...

A US sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ... the following year, SRF (which had ...

SRF reported a 41% rise in Ebitda to ₹1,000 crore. Revenue increased by 21% to ₹4,300 crore, benefiting from enhanced demand ...

SRF’s Chemicals Business was the standout performer in the March quarter (Q4FY25), with revenue jumping 30 percent year-on-year from ₹1,816 crore to ₹2,355 crore. The segment's operating profit surged ...

The chemical manufacturer's consolidated bottom line stood at Rs 526 crore in the quarter ended March 31, 2025.

Domestic sales now form 25-30% of chemicals business versus 5% three years ago ... So far in 2024, SRF’s shares are down 8%, far below the Nifty Midcap 50 index's 23% returns.